Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immune function regulation
- Molecular classification
- Other (Process; not a single defined molecule or protein), Includes multiple: receptor, enzyme, transcription factor, cytokine, metabolic regulator, etc.
01
Overview
Immune function regulation" refers collectively to the numerous interconnected pathways, cellular mechanisms, and molecular signals that control the magnitude, quality, and duration of immune responses. These mechanisms include the action of cytokines (IL-6, IL-10, TGF-β), immune checkpoints (PD-1, CTLA-4), metabolic regulators (mTOR, sirtuins), and epigenetic controls (miRNA, DNA methylation, histone modification), among others. The primary biological purpose of immune regulation is to maintain immune homeostasis, preventing both overactive responses (autoimmunity, excessive inflammation) and underactive states (immunodeficiency). Abnormalities in immune regulatory mechanisms contribute to the pathogenesis of cancer, autoimmunity, chronic inflammatory states, and various metabolic disorders. The therapeutic modulation of these pathways is a central strategy in the treatment of related diseases.
- Other names
- Immune regulationImmunomodulationRegulation of immune responseImmune homeostasis
02
Mechanism of action
Inhibition or activation of cytokine signaling; Checkpoint modulation (PD-1, CTLA-4); Metabolic pathway modulation (e.g., mTOR, glycolysis).
03
Biological functions
Immune responseImmunological toleranceSignal transductionCell activation/suppressionCytokine productionCell proliferationCell death
04
Disease associations
Cancer (e.g., immune checkpoint dysfunction)Autoimmune diseases (e.g., rheumatoid arthritis, multiple sclerosis, lupus)Chronic inflammationMetabolic diseasesInfectious diseases
05
Safety considerations
Excessive immunosuppression (risk of infection, cancer)Cytokine storm (excessive immune activation)Autoimmunity (insufficient regulation)Off-target metabolic effects
06
Interacting drugs
Immunomodulators (e.g., corticosteroids, biologics targeting cytokines such as anti-TNF or anti-IL-6 agents)
2 more in the full profile.
07
Biomarkers
Cytokine levels (e.g., IL-6, IL-10, TGF-β)Immune checkpoint molecule expression (PD-1, CTLA-4)Regulatory T cell (FOXP3) levelsMetabolic markers (e.g., mTOR activity, glycolytic enzymes)
Beyond the preview
Go deeper on Immune function regulation.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Immune function regulation.